Past Webinars

February 24, 2021 – noon E.S.T. – CDMO Business Development & Marketing During the Pandemic

How do you conduct Sales & Marketing and Business Development when there’s no business travel, no in-person trade shows, no site visits, and a whole lot of Zoom calls?

Two of PBOA’s Affiliate Members, SCORR Marketing and ramarketing PR, joined forces with PBOA members Bora Pharmaceuticals and Metrics Contract Services for this panel conversation and Q&A about adapting to The New Abnormal, and what lessons may carry over to the post-pandemic era.

This exclusive PBOA event was recorded. Please contact us if you belong to a PBOA member company and would like a link to the video.

PANELISTS

Lea LaFerla

Vice President of Marketing Services & Business Development – SCORR Marketing

With more than 20 years of sales and marketing experience in the clinical diagnostic and pharmaceutical industries, Lea leads the client services team, managing a portfolio of global clients specific to the health sciences. Lea contributes her industry knowledge, pharmaceutical experience, and understanding of clients to develop results-oriented integrated marketing programs that are on budget, on time and defect-free.

Prior to joining SCORR, Lea was a sales representative at Merck. More recently, as marketing director and director of stabilization and flow products at Streck, she led product acquisitions, launched new products, developed growth strategies and oversaw domestic and international sales and marketing teams.

* * *

Raman Sehgal

Founder & Global President – ramarketing PR

Raman is the founder of ramarketing, which is a global marketing agency that specialises in the life science sector. He has advised 100+ companies across healthcare and the drug development supply chain, helping them create marketing strategies. From niche CROs to multinational blue-chip CDMOs to fast-growing tech companies, Raman helps companies grow.  An international keynote speaker, regular blogger and university guest lecturer, Raman is also host of the outsourcing industry’s leading podcast – Molecule to Market podcast.

Today, he oversee the company’s US operations from Boston, MA. He is as thirsty as ever for knowledge in a bid to perfect his craft, nurture his business and support more companies that operate in the pharma and biotech sector.

* * *

Sam Ricchezza

President, North American Operations – Bora Pharmaceuticals

In his current role as President, North American Operations at Contract Development and Manufacturing Organization (CDMO), Bora Pharmaceuticals, Sam Ricchezza is responsible for advancing Bora’s North American growth strategy.  He has more than 25 years’ CDMO experience, and prior to joining Bora, he was President of WellSpring Pharma Services and led the company through a sale of the business.  Before that, he previously held progressively responsible Business Development and Marketing roles at companies such as Patheon, DPT Labs, AAIPharma (Alcami) and Diteba Research Laboratories.

Sam currently serves on the Board of the Pharmaceutical Sciences Group and is a member of the Mississauga Board of Trade’s Mississauga Economic Recovery Group initiative and the City of Mississauga Economic Development Office, Entrepreneurship & Innovation Advisory Board.  Sam has previously served as Secretary of the Board of Trustees with the Pharma & Biopharma Outsourcing Association.

* * *

John Ross

President – Mayne Pharma • Metrics Contract Services

John Ross has more than 20 years’ experience in the pharmaceutical industry across marketing and sales, manufacturing and distribution, global sourcing and supply chain. Prior to joining Mayne Pharma, Mr. Ross was a Principal at Tunnell Consulting a leading US biotech and pharmaceutical consulting organization. He has also held a number of leadership roles including Chief Operating Officer of Contract Pharmaceuticals Limited, a provider of outsourced third-party contract development, manufacturing and testing of pharmaceuticals. John joined Mayne Pharma in 2013 to head up the Metrics Contract Services division shortly after Mayne acquired Metrics.  Since then, Metrics has nearly tripled in revenue, doubled its headcount, and expanded its service offering to include global commercial supply.  Metrics was a founding member of PBOA and John was part of the inaugural Board of PBOA. John became President of Mayne Pharma US several years ago, adding US Quality, Operations and Supply Chain to his scope for Mayne Pharma.  John continues to lead the Metrics Contract Services division.

This FREE webinar is ONLY for PBOA members. Not a PBOA member yet? For membership information, contact Gil Roth at gil.roth@pharma-bio.org or +1-201-788-7994